ÎÂůËÄÐò(ÓñÈËÊÖÎÞа̬±ÚÖ½) - ÓñÈËÊÖ»ú±ÚÖ½ÏÂÔØ..."/> ÓÈÆäÊÇ˹ĦÀâ˹¿ËµÄÂùݣ¬ÕâÀïÔ±¾ÊÇÓο͵ÄÐÝÏ¢Ö®´¦£¬ÏÖÔÚ³¹µ×ÂÙΪµÂ¹úÈ˵ļËÔº£¬ÌìÌì¶¼Óдó×ÚµÄËÕÁª¸¾Å®±»×¥µ½ÕâÀï²ÒÔâÁèÈ裬ÖÁÓÚ±»·ýµÄËÕ¾üÊ¿±ø£¬Ôò±»²ÐÈ̵ĶöËÀÔÚÕ½·ýÓªÀï¡£"/>
¡¶ÎÂůËÄÐò(ÓñÈËÊÖÎÞа̬±ÚÖ½) - ÓñÈËÊÖ»ú±ÚÖ½ÏÂÔØ...¡·¾çÇé¼ò½é£ºÓÈÆäÊÇ˹ĦÀâ˹¿ËµÄÂùÝÕâÀïÔ±¾ÊÇÓο͵ÄÐÝÏ¢Ö®´¦ÏÖÔÚ³¹µ×ÂÙΪµÂ¹úÈ˵ļËÔºÌìÌì¶¼Óдó×ÚµÄËÕÁª¸¾Å®±»×¥µ½ÕâÀï²ÒÔâÁèÈèÖÁÓÚ±»·ýµÄËÕ¾üÊ¿±øÔò±»²ÐÈ̵ĶöËÀÔÚÕ½·ýÓªÀï¾ÍËãÊÇһλÎä¾ýËļ¶µÄÇ¿ÕßÒ²²»¸ÒÕâô¶Ô¿¹ÀË·ÌìÈ«Á¦Ò»»÷ÊÂʵʵÁ¦ÊÇʵÁ¦·ÀÓùÊÇ·ÀÓùʵÁ¦Ç¿Ê¢µÄÈË·×Æç¶¨·ÀÓùÁ¦Ò²ºÜǿʢÎÂůËÄÐò(ÓñÈËÊÖÎÞа̬±ÚÖ½) - ÓñÈËÊÖ»ú±ÚÖ½ÏÂÔØ...»Êλ¼ÌÐøÐÄ̬µÄÉç»á²¡Ôî£ºÍøÓÑÈÈÒé½Ò¿ªÁ˸üÉî²ãÉ˰̣º2025ÄêÁËÉÐÓÐÈ˰Ñ×Ó¹¬µ±¼Ò×å¼À̳Éç»áѧר¼ÒÖ¸³ö´ËÀà°¸¼þÕÛÉä³öÈý´óì¶Ü£º
¡¶ÎÂůËÄÐò(ÓñÈËÊÖÎÞа̬±ÚÖ½) - ÓñÈËÊÖ»ú±ÚÖ½ÏÂÔØ...¡·ÊÓÆµËµÃ÷£ºÒÔºó²»ÊÇÁËΪÁË×èÖ¹ËûÈËðÓÃÔÚµç×ÓÔÝʱ³Ë³µÉí·Ý֤ʵ¶þάÂëʹÓÃÒ³ÃæÍ£Áô30·ÖÖÓºóÐèÒªÓû§ÖØÐÂͨ¹ýʵÈ˺ËÑéÈ·¶¨×Ô¼º²Ù×÷ÔÚÔÝʱ³Ë³µÉí·Ý֤ʵÓÐÓÃÆÚÄڸòÙ×÷²»Õ¼ÓÃÉêÇë´ÎÊýWu et al. Roxadustat and Oral Iron Absorption in Chinese Patients with Anemia of Chronic Kidney Disease. Advances in Therapy, 2024.
Îôʱ·½Ô´´Ù³ÉµÄËÄ×å´óͬÃË×ÅʵÔç¾ÍΪ½ñÕâÑùµÄÇé¾°×öÁË˼Á¿×ª×ÔÄϾ©ÎÀÉú12320
2025-10-15 09:28:55